The reporting on ERAS Compliance, Outcomes, and Elements Research (RECOvER) checklist: a joint statement by the ERAS® and ERAS® USA societies by Elias, Kevin M. et al.
ORIGINAL SCIENTIFIC REPORT
The Reporting on ERAS Compliance, Outcomes, and Elements
Research (RECOvER) Checklist: A Joint Statement
by the ERAS and ERAS USA Societies
Kevin M. Elias1 • Alexander B. Stone2 • Katharine McGinigle3 • Jo’An I. Tankou1 •
Michael J. Scott4,5 • William J. Fawcett6 • Nicolas Demartines7 • Dileep N. Lobo8 •
Olle Ljungqvist9 • Richard D. Urman2 on behalf of the ERAS Society and ERAS USA
 The Author(s) 2018
Abstract
Background Enhanced recovery after surgery (ERAS) programs are multimodal care pathways designed to minimize
the physiological and psychological impact of surgery for patients. Increased compliance with ERAS guidelines is
associated with improved patient outcomes across surgical types. As ERAS programs have proliferated, an unin-
tentional effect has been significant variation in how ERAS-related studies are reported in the literature.
Methods To improve the quality of ERAS reporting, ERAS USA and the ERAS Society launched an effort to
create an instrument to assist authors in manuscript preparation. Criteria to include were selected by a combination of
literature review and expert opinion. The final checklist was refined by group consensus.
Results The Societies present the Reporting on ERAS Compliance, Outcomes, and Elements Research (RECOvER)
Checklist. The tool contains 20 items including best practices for reporting clinical pathways, compliance auditing,
and formatting guidelines.
Conclusions The RECOvER Checklist is intended to provide a standardized framework for the reporting of ERAS-
related studies. The checklist can also assist reviewers in evaluating the quality of ERAS-related manuscripts.
Authors are encouraged to include the RECOvER Checklist when submitting ERAS-related studies to peer-reviewed
journals.
& Kevin M. Elias
kelias@bwh.harvard.edu
1 Division of Gynecologic Oncology, Department of
Obstetrics, Gynecology and Reproductive Biology, Brigham
and Women’s Hospital, Harvard Medical School, 75 Francis
Street, Boston, MA 02115, USA
2 Department of Anesthesiology, Perioperative and Pain
Medicine, Brigham and Women’s Hospital, Harvard Medical
School, Boston, MA, USA
3 Division of Vascular Surgery, University of North Carolina
School of Medicine, Chapel Hill, NC, USA
4 Department of Anesthesiology, Virginia Commonwealth
University Health System, Richmond, VA, USA
5 Department of Anesthesiology, Perelman School of
Medicine, University of Pennsylvania, Philadelphia, PA,
USA
6 Department of Anaesthesia, Royal Surrey County Hospital
and University of Surrey, Guilford, UK
7 Department of Visceral Surgery, Lausanne University
Hospital CHUV, Lausanne, Switzerland
8 Gastrointestinal Surgery, Nottingham Digestive Diseases
Centre and National Institute for Health Research (NIHR)
Nottingham Biomedical Research Centre, Nottingham
University Hospitals NHS Trust and University of
Nottingham, Queen’s Medical Centre,
Nottingham NG7 2UH, UK
9 Department of Surgery, Faculty of Medicine and Health,
School of Health and Medical Sciences, O¨rebro University,
O¨rebro, Sweden
123
World J Surg
https://doi.org/10.1007/s00268-018-4753-0
Introduction
Enhanced recovery after surgery (ERAS) programs are
multimodal care pathways designed to minimize the
physiological and psychological impact of surgery for
patients. ERAS pathways rely on multidisciplinary teams
and require coordinated interventions in all parts of peri-
operative care, from the initial preoperative consultation
through the hospitalization and onward to the return of the
patient to normal activities of daily living [1]. ERAS pro-
grams reduce hospital lengths of stay and postoperative
complications while decreasing the costs of care for
patients and health systems [2, 3]. Most ERAS pathways
are designed around approximately 25 core elements out-
lined by the ERAS Society [4]. There are data to suggest
that increased compliance with these core elements is
associated with improved outcomes across surgical types
[5–8].
In recent years, research in ERAS has expanded sig-
nificantly. ERAS programs have expanded beyond col-
orectal surgery to other surgical disciplines and have been
implemented successfully in pancreatic surgery, thoracic
surgery, liver resection, urologic surgery, gynecologic
surgery, and emergency surgery, among others [5, 9–13].
An unintentional effect of this rapid expansion has been
significant variations in how ERAS studies are reported
[14]. The COMPAC (Core Outcome Measures in Periop-
erative and Anaesthetic Care) group has embarked on an
effort to standardize the outcomes reported in perioperative
medicine https://www.niaa-hsrc.org.uk/HSRC-COMPAC.
While there are some efforts to apply a similarly tiered
approach to reporting ERAS outcomes, we believe that a
truly comprehensive ERAS report should detail not only
the outcomes, but also the process by which those out-
comes were achieved [15]. Like any other scientific
enterprise, the methods should contain sufficient detail to
enable another group to reproduce the results. Moreover, as
ERAS protocols have now been in place at many sites for
years, there is a need to mature ERAS studies beyond the
common retrospective comparisons to pre-ERAS historic
controls. These lower-quality studies tend to magnify the
benefits of the intervention being studied. Indeed, properly
designed prospective studies have been revealing, showing
that interventions which may improve outcomes under
traditional perioperative management do not necessarily
confer additional benefit when both groups are on ERAS
pathways [16]. Hence, there is a need to formalize ERAS-
related research such that meaningful results are repro-
ducible and generalizable. We created the Reporting on
ERAS Compliance, Outcomes, and Elements Research
(RECOvER) Checklist to provide authors and reviewers
with a set of standards for excellence in reporting ERAS-
related studies. This checklist is not a guideline itself—in
fact, quite the opposite. It is a tool to assist authors when
reporting outcomes on guidelines already in practice and, if
anything, should prompt reviewers or readers to ask why
elements in a report are not described or may not be
appropriate. Our goal is to encourage reproducibility in
clinical studies, acknowledging the different variables
which may influence ERAS outcomes and the different
ways in which ERAS has been implemented in units
around the world. This is not a meta-analysis; rather, we
aim to improve study reporting so that future meta-analyses
can be more easily performed by ensuring sufficient
information on ERAS practice and description of
outcomes.
RECOvER development
A checklist and statement were developed by a small
working group of volunteers from ERAS USA (the
American chapter of the ERAS Society). A subcommittee
(KME, KM, JIT) from the ERAS USA Research Com-
mittee reviewed ERAS-related publications from across
different medical specialties and study designs. In devel-
oping the checklist, subcommittee members were asked to
review 10–15 manuscripts each from anesthesia, surgery,
or general interest journals and tasked to define best
practices in ERAS reporting. Questions to be addressed
were:
1. How are the study groups defined?
2. How do the authors convey the implementation of
ERAS principles?
3. What steps are taken to assess compliance?
4. What outcomes are measured?
This subcommittee developed an initial list of 32 items
for inclusion in a checklist of best practices. After dis-
cussion with the larger committee, this number was
reduced to 20 items to focus the checklist on elements
related to ERAS rather than to general guidelines for best
practices in research reporting. The total number of ele-
ments was reduced by removing those redundant with
general reporting guidelines, for example the Enhancing
QUAlity and Transparency Of health Research (EQUA-
TOR) network guidelines, or by combining similar ele-
ments to make the checklist more concise [17].
Reconciliation in the rare cases where disagreement
occurred was achieved by following the majority opinion
of the authors. After agreement in the Research Committee
was achieved, the checklist was circulated to members of
the ERAS Society Executive Committee (MJS, WJF, ND,
DNL, and OLP) for further comments. Following feedback
from members of the society, the final number of 20 items
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Table 1 RECOvER Checklist for reporting of enhanced recovery research
Item Recommendation Page
Title
Title 1 Indicate that this is an enhanced recovery study in the title
Introduction
Background 2 Explain the area of uncertainty that the study seeks to address
Guidelines 3 If a published set of enhanced recovery guidelines exists for this procedure, include a reference to the
guidelines
Outcomes 4 Define the primary outcome and any key prespecified secondary outcomes for the study
Methods
IRB approval 5 Give the Institutional Review Board/Ethics Committee name and approval number. If permission was not
required, reasons should be stated
Study design 6 Indicate what type of study is presented (randomized controlled trial, cohort, cross-sectional, etc.) The
individual guidelines for the type of study should be followed (e.g., CONSORT for randomized
controlled trial, STROBE for cohort studies, etc.)
Setting 7 Describe whether this is a single or multicenter study, the type of practice (academic vs. community,
tertiary vs. primary), and the providers (limited group or all providers on a service)
Timing 8 Describe periods of recruitment, time points at which outcomes assessed, and follow-up
Participants 9 Define study inclusion and exclusion criteria
Enhanced recovery
protocol
10 Describe when the enhanced recovery protocol was implemented relative to the study period
11 Provide a flow diagram or table through the continuum of care detailing the enhanced recovery protocol
including the following elements:
(a) Preadmission patient education regarding the protocol
(b) Preadmission screening and optimization as indicated for nutritional deficiency, frailty, anemia,
HbA1c, tobacco cessation, and ethanol use
(c) Fasting and carbohydrate loading guidelines
(d) Preemptive analgesia (dose, route, timing)
(e) Anti-emetic prophylaxis (dose, route, timing)
(f) Intraoperative fluid management strategy
(g) Types, doses, and routes of anesthetics administered
(h) Patient warming strategy
(i) Management of postoperative fluids
(j) Postoperative analgesia and anti-emetic plans
(k) Plan for opioid minimization
(l) Drain and line management
(m) Early mobilization strategy
(n) Postoperative diet and bowel regimen management
(o) Criteria for discharge
(p) Tracking of post-discharge outcomes
Enhanced recovery
auditing
12 Describe the audit system for compliance with the enhanced recovery protocol and how compliance data
are measured
Outcomes 13 (a) Explain the criteria for assessing primary and secondary outcomes
(b) Distinguish among clinical, functional, administrative, and quality of life outcome measures
PROs 14 If patient questionnaires are used, provide references to validation of these study instruments
Results
Patient population 15 Use a flow diagram to explain the derivation of the study population
(a) Provide a Table I with the key demographic and clinical features of the study population
(b) Indicate number of participants with missing data for each variable of interest
Enhanced recovery
compliance
16 Provide a Table II with average compliance for each enhanced recovery protocol element and present a
comparison of the variation in enhanced recovery compliance among the study groups
Correlations 17 Perform logistic regression to correlate the change in primary outcome with the study intervention
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was confirmed by consensus agreement by the members of
the Research Committee and Standards and Protocols
Committee of ERAS USA (ABS, RDU).
RECOvER items
The complete list of checklist items is shown in Table 1.
We recommend that authors publishing research in the field
of ERAS include this checklist with their submissions and
indicate the location of each item in the manuscript. This is
a framework for guidance. It should facilitate publication
rather than serve as a barrier. The ultimate decision to
accept or reject manuscripts is with the individual journal
editors; the guidance is not proscriptive. Each item in the
checklist pertains to a particular point in the course of
conducting an ERAS research study, from conceptualiza-
tion to data analysis and the writing of the manuscript.
Therefore, we recommend that the researchers consult the
checklist as early as possible during the study planning
process. Below we provide a detailed description of each
checklist item, followed by some examples.
Reporting standards begin with the title page. ERAS
studies should refer to enhanced recovery within the title
(item 1), which will facilitate queries for future systematic
reviews. The title should also relay the study type and
surgical procedure studied—for example, a retrospective
cohort study of patients undergoing robotic-assisted pan-
creaticoduodenectomies. In the introduction, the authors
should explain the specific area of clinical uncertainty
being addressed within the context of ERAS (item 2)—for
instance, whether high-volume or high-concentration local
anesthetic provides superior local analgesia to the incision.
As the ERAS Society and other perioperative research
societies have published guidelines for many procedures,
existing guidelines, if applicable, should be referenced
(item 3). The primary outcome for the study should be
clearly stated in the introduction, as well as key secondary
outcomes of interest (item 4). While many ERAS studies
have focused on administrative outcomes, such as hospital
length of stay, or clinical outcomes, such as wound infec-
tion or transfusion rates, there is considerable need for
more ERAS studies addressing functional outcomes. The
latter might include outcomes such as return to work or
discharge to home rather than to a rehabilitation facility
[18–20]. There is also a need for more studies examining
non-surgical perioperative morbidity within the context of
established ERAS programs, such as the consequences of
preoperative anxiety or postoperative delirium [21, 22].
Within the materials and methods, all ERAS studies
should describe the Institutional Review Board (IRB) or
Ethics Committee review or explain the rationale for IRB/
Ethics Committee exemption (item 5). The study design,
including whether this is a prospective or retrospective
study, should be evident (item 6). The design description
should include details on the clinical context, including the
setting (item 7), timing (item 8), and selection of patients
(item 9) for the study. This includes the type of hospital,
period of recruitment, and inclusion and exclusion criteria
for the study. The authors should place the report tempo-
rally with respect to the introduction of ERAS at the
institution (item 10), including differentiating pre-ERAS
from post-ERAS groups of patients. An explicit statement
regarding the dates of introduction of ERAS at the insti-
tution, if possible, is preferred. Paramount to ERAS-related
studies is documentation that the principles of enhanced
recovery are being followed (item 11). While the literature
is rife with reports of ERAS failures, a closer inspection
may reveal a lack of compliance with ERAS concepts
[23, 24]. A detailed description of the ERAS pathway
should cover all phases of care (preadmission, preopera-
tive, intraoperative, post-anesthesia care, inpatient, post-
discharge, and follow-up care). The description should also
include the management strategies for perioperative opti-
mization, opioid-sparing analgesia, fluid management,
avoidance of starvation, nutritional care, mobilization, and
discharge. These elements must then be related to an audit
system for pathway compliance (item 12), whether the
ERAS Interactive Audit System (EIAS) or local
databases. The report should include a list of the metrics
Table 1 continued
Item Recommendation Page
Discussion
Context 18 Explain what the study adds to the body of knowledge regarding the study intervention within the context
of enhanced recovery after surgery care
Limitations 19 Discuss the limitations of the study and how these might temper the findings
Other information
Funding 20 Document all sources of funding and potential conflicts of interest for the study authors
RECOvER Reporting on ERAS Compliance, Outcomes, and Elements Research, CONSORT Consolidated Standards Of Reporting Trials,
STROBE STrengthening the Reporting of OBservational studies in Epidemiology, PROs patient-reported outcomes
World J Surg
123
Table 2 Example of a RECOvER Checklist
Item Recommendation Page
Title
Title 1 Gum chewing improves recovery of gut function within an enhanced recovery protocol for hepatic
resection
1
Introduction
Background 2 Whether gum chewing offers additional benefit for functional gut recovery after liver resection beyond
other enhanced recovery elements is uncertain
3
Guidelines 3 Melloul E, et al. World J Surg 2016 Oct;40(10):2425–2440 3
Outcomes 4 Primary outcome Time to first bowel movement after surgery
Secondary outcomes Incidence of postoperative ileus, length of stay, incidence of postoperative emesis
3
Methods
IRB approval 5 General Hospital IRB #123456 4
Study design 6 Retrospective cohort study 4
Setting 7 Single institution, community-based academic hospital with stable group of surgeons during the study
period
5
Timing 8 Patients included from March 2013–May 2015, events assessed daily from surgery to discharge, all
patients followed until 2-week postoperative visit
5
Participants 9 Inclusion criteria 18? years old, participating in the enhanced recovery protocol, undergoing hepatic
resection, not admitted to ICU postoperatively
Exclusion criteria Age\18, unable or unwilling to participate in enhanced recovery protocol, other
surgical procedures, ICU admission
5
Enhanced recovery
protocol
10 enhanced recovery protocol was initiated in March 2012 6
11 Provide a flow diagram or table through the continuum of care detailing the enhanced recovery protocol
including the following elements:
7
(a) Preadmission patient education regarding the protocol
All patients receive an informational packet, watch a 10-minute video, and attend a 1-h preoperative
educational class
(b) Preadmission screening and optimization for nutritional deficiency, frailty, tobacco cessation, and
ethanol use
Patients are screened for nutritional deficiency using the NRS scoring system, frailty using the scoring
model published by Kim et al. and referred preoperatively for tobacco and ethanol counseling
(c) Fasting and carbohydrate loading guidelines
Normal diet until midnight, clear liquids until 2 h before surgery, 300-ml isotonic beverage containing a
total of 50 grams of maltodextrin finished 2 h before surgery
(d) Preemptive analgesia (dose, route, timing)
300 mg celecoxib, 500 mg acetaminophen both oral given in pre-op
(e) Anti-emetic prophylaxis (dose, route, timing)
4 mg ondansetron and 8 mg dexamethasone given intravenously prior to emergence
(f) Intraoperative fluid management strategy
Esophageal Doppler monitoring of stroke volume variation
(g) Types, doses, and routes of anesthetics administered
Continuous propofol, intravenous lidocaine, and low-dose ketamine infusion, no volatile anesthesia
(h) Patient warming strategy
Forced warm air and intravenous fluid warmer
(i) Management of postoperative fluids
0.5 ml/kg/h 9 6 h
(j) Postoperative analgesia and anti-emetic plans
0.25% liposomal bupivacaine wound infiltration, 500 mg acetaminophen and 600 mg ibuprofen every 6 h
orally, 4 mg ondansetron every 6 h intravenously as needed
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that enter into the compliance calculation. Similarly, out-
comes, both primary and secondary, should be clearly
defined a priori (item 13), and whenever patient-reported
outcomes (PROs) or surveys are introduced, these should
use validated and referenced instruments (item 14).
Results reporting in ERAS should reflect similar trans-
parency to the methods. The reader should be able to
visualize the derivation and composition of the study
population (item 15). A description of the population
should identify what proportion of all patients undergoing
the procedure of interest is being reported and the reasons
for exclusion from the study. The outcomes results should
be displayed in the context of the actual compliance with
the ERAS elements (item 16). Again, this requires an
Table 2 continued
Item Recommendation Page
(k) Plan for opioid minimization
First-line analgesic 25 mg tramadol every 6 h orally as needed, increased to 50 mg tramadol if needed,
followed by addition of IV lidocaine infusion if needed, followed by pregabalin 100–300 mg every 8 h
if needed, followed by 5–10 mg oral oxycodone for breakthrough pain
(l) Drain and line management
No routine wound drains, Foley catheter removed in OR
(m) Early mobilization strategy
Patients ambulate to chair in PACU, ambulate 9 3 starting postoperative day 0, out of bed all meals, out
of bed 8 h per day starting postoperative day 1
(n) Postoperative diet and bowel regimen management
Clear liquids post-op day 0, regular diet beginning post-op day 1, standing MiraLax daily beginning
post-op day 0
(o) Criteria for discharge
Tolerating at least 2000 ml po daily, voiding independently, pain well controlled on oral medication,
ambulating in hallways
(p) Tracking of post-discharge outcomes
Patients contacted by office through daily email survey
Enhanced recovery
auditing
12 All enhanced recovery elements charted by physician assistant into Enhanced Recovery Interactive Audit
System (EIAS)
8
Outcomes 13 (a) Primary outcome Bowel movement as documented by RN
Secondary outcomes Per patient report as collected by physician assistant interview
9
(b) Clinical outcomes
PROs 14 European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-C30 (J Clin
Epidemiol 2014)
9
Results
Patient population 15 See Figure 1 (or similar) 10
(a) See Table 1 (or similar) 11
(b) Participants with missing data indicated in Table 1 footnotes 11
Enhanced recovery
compliance
16 Table II provides enhanced recovery compliance for the gum-chewing versus non-gum-chewing groups
for 15 metrics from the enhanced recovery pathway
12
Correlations 17 Table III provides logistic regression examining gum chewing with respect to primary and secondary
outcomes
13
Discussion
Context 18 Study suggests that gum chewing has additional benefits to standard bowel regimen, early feeding, and
laxative guidelines for promoting early return of gut function
15
Limitations 19 Not a prospective study, did not have sufficient power to subdivide patients by indication for hepatic
resection, poor compliance among the cohort with respect to early mobilization and termination of
intravenous fluids
16
Other information
Funding 20 Support from departmental grant 2
RECOvER Reporting on ERAS Compliance, Outcomes, and Elements Research, IRB Institutional Review Board, ICU intensive care unit,
NRS nutrition risk screening, PACU post-anesthesia care unit
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auditing system in place so that percentage compliance
with the protocol can be plotted against the outcomes of
interest. Whenever possible, regression analysis techniques
should be used to test for independent associations between
the primary outcome and the intervention under study (item
17). For example, in a study of ambulation from the
postoperative recovery unit compared to ambulation on
reaching the inpatient ward, where the primary outcome is
actually the 6-minute walk test result at 2 weeks after
surgery, a regression analysis should include confounders
for early ambulation such as time of day, neuraxial anal-
gesia, or receipt of opioids.
The discussion of ERAS studies should place the work
within the larger context of ERAS-related care (item 18).
Authors should strive to link the findings with tangible
opportunities to improve clinical practice. A study that
shows a decrease in visual analog scale (VAS) pain scores
from 5 to 4 is of much less impact on the field than a
similar study that examines the proportion of patients dis-
charged to home rather than to a rehabilitation facility.
Authors sometimes consciously or subconsciously overin-
terpret the results of their study, that is, they add ‘‘spin’’ to
the conclusions of a scientific report. Spin is defined as a
non-neutral way of reporting that distorts the interpretation
of results and misleads readers [25]. An appraisal of the
study limitations should be candid (item 19), including
critiques of the ERAS protocol itself, if indicated. Finally,
authors must be open regarding funding support and pos-
sible conflicts of interest (item 20).
RECOvER scope
An example of the RECOvER Checklist appears in
Table 2. The primary aim of the RECOvER Checklist is to
ensure an ERAS-specific addendum accompanies ERAS-
related studies so that the reader can assess the ERAS-
specific elements. The checklist is not mandatory; rather, it
serves as a framework to make it easier to compare ERAS
studies and assemble future systematic reviews and meta-
analyses.
RECOvER Checklist availability
The RECOvER Checklist will be made available on the
ERAS USA as well as the ERAS Society websites. It is
free and available as an open access document to support
higher-quality and more consistent reporting of ERAS
research.
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